Marianne De Backer's Insider Trades & SAST Disclosures
Marianne De Backer's most recent trade in Vir Biotechnology Inc was a trade of 480,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 22, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Marianne De Backer.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vir Biotechnology Inc | Marianne De Backer | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2025 | 480,000 | 480,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Marianne De Backer | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2025 | 240,000 | 865,339 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Marianne De Backer | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 9.45 per share. | 22 Feb 2025 | 16,122 | 849,217 (0%) | 0% | 9.5 | 152,408 | Common Stock |
| Vir Biotechnology Inc | Marianne De Backer | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 12 Jun 2024 | 53,118 | 625,339 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Marianne De Backer | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 12 Jun 2024 | 53,118 | 53,118 (0%) | 0% | 0 | Common Stock | |
| Vir Biotechnology Inc | Marianne De Backer | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 9.46 per share. | 03 Apr 2024 | 72,995 | 678,457 (0%) | 0% | 9.5 | 690,365 | Common Stock |
| Vir Biotechnology Inc | De Backer Marianne | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 350,000 | 350,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Marianne De Backer | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 175,000 | 751,452 (0%) | 0% | 0 | Common Stock | |
| Kronos Bio Inc | Marianne De Backer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 34,000 | 34,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Marianne De Backer | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 1,152,904 | 1,152,904 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Marianne De Backer | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 576,452 | 576,452 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharmaceuticals ... | Marianne De Backer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2023 | 7,867 | 31,267 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharmaceuticals ... | Marianne De Backer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2023 | 4,593 | 4,593 | - | - | Common Stock | |
| Kronos Bio Inc | Marianne De Backer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 17,000 | 17,000 | - | - | Stock Option (Right to Buy) | |
| Kronos Bio Inc | Marianne De Backer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 11,333 | 14,083 | - | 0 | Common Stock | |
| Arrowhead Pharmaceuticals ... | Marianne De Backer | Director | Sale of securities on an exchange or to another person at price $ 64.25 per share. | 03 Jan 2022 | 2,244 | 19,256 (0%) | 0% | 64.3 | 144,177 | Common Stock |
| Arrowhead Pharmaceuticals ... | Marianne De Backer | Director | Sale of securities on an exchange or to another person at price $ 65.01 per share. | 03 Jan 2022 | 1,984 | 17,272 (0%) | 0% | 65.0 | 128,980 | Common Stock |
| Arrowhead Pharmaceuticals ... | Marianne De Backer | Director | Sale of securities on an exchange or to another person at price $ 66.25 per share. | 03 Jan 2022 | 272 | 17,000 (0%) | 0% | 66.3 | 18,020 | Common Stock |
| Kronos Bio Inc | Marianne De Backer | Director | Purchase of securities on an exchange or from another person at price $ 11.57 per share. | 01 Dec 2021 | 1,150 | 2,750 | - | 11.6 | 13,306 | Common Stock |
| Kronos Bio Inc | Marianne De Backer | Director | Purchase of securities on an exchange or from another person at price $ 19.63 per share. | 20 Aug 2021 | 500 | 1,600 | - | 19.6 | 9,815 | Common Stock |
| Kronos Bio Inc | Marianne De Backer | Director | Purchase of securities on an exchange or from another person at price $ 19.50 per share. | 20 Aug 2021 | 500 | 1,100 | - | 19.5 | 9,750 | Common Stock |
| Arrowhead Pharmaceuticals ... | Marianne De Backer | Director | Sale of securities on an exchange or to another person at price $ 89.85 per share. | 24 Jun 2021 | 5,000 | 21,500 (0%) | 0% | 89.9 | 449,250 | Common Stock |
| Kronos Bio Inc | Marianne De Backer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 8,583 | 8,583 | - | - | Stock Option (Right to Buy) | |
| Kronos Bio Inc | Marianne De Backer | Director | Purchase of securities on an exchange or from another person at price $ 25.01 per share. | 28 May 2021 | 600 | 600 | - | 25.0 | 15,006 | Common Stock |
| Kronos Bio Inc | Marianne De Backer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2021 | 41,200 | 41,200 | - | - | Stock Option (right to buy) | |
| Arrowhead Pharmaceuticals ... | Marianne De Backer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2021 | 9,000 | 26,500 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharmaceuticals ... | Marianne De Backer | Director | Purchase of securities on an exchange or from another person at price $ 50.00 per share. | 08 Oct 2020 | 500 | 17,500 (0%) | 0% | 50 | 25,000 | Common Stock |
| Arrowhead Pharmaceuticals ... | Marianne De Backer | Director | Purchase of securities on an exchange or from another person at price $ 50.93 per share. | 08 Oct 2020 | 500 | 17,000 (0%) | 0% | 50.9 | 25,465 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges